Sosei Heptares Receives Grant Funding from Wellcome to Advance the Development of Potent, Differentiated Oral Anti-Viral Small Molecules to Treat COVID-19
/PRNewswire/ -- Sosei Group Corporation ("the Company"; TSE: 4565) today announced it has received grant funding from Wellcome, through the COVID-19...
Source: prnewswire.com